Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

German patients vulnerable to medical malpractice:

This article was originally published in Clinica

Executive Summary

Patients in Germany are not able to properly protect themselves from faulty or unsafe methods of treatment claims the federal association for consumer protection (VZBV). Speaking in Berlin last week, Thomas Isenberg of the VZBV said that patients were given limited information about operations. They should be given details about the frequency of the operation they were to undergo and also the possibility of medical mistakes being made. Mr Isenberg added that it was too often the case that patients were at the mercy of the commercial interests of the doctors, pharmacists other healthcare providers. A study published last week by Transparency International (TI), showed that each year German hospitals deal with some 200,000 cases resulting from incorrectly-prescribed pharmaceuticals. Between 5,000-8000 patients die yearly as a result of these mistakes.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel